Hip Scope Fascia-iliaca (FI) Block Study

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Preemptive Femoral & Lateral Femoral Cutaneous Nerve Blocks for THA Acute Pain

NCT01997567

Internal Derangement of Hip Acetabular Labrum Tear

TERMINATED NA

Hip Arthroscopy; Femoral Nerve Block or Fascia Iliaca Block

NCT05010499

Anlgesia for Hip Arthroscopy by Assessing Quality of Different Type of Regional Block, Femoral Nerve Block Versus Fascia Iliaca Block

UNKNOWN PHASE4

Fascia Iliaca Compartment Blocks for Pain Control in Hip Fractures

NCT04086914

Hip Fractures

WITHDRAWN EARLY_PHASE1

Fascia Iliaca Block for Postoperative Pain Control After Elective Hip Arthroplasty

NCT06534697

Hip Osteoarthritis

NOT_YET_RECRUITING NA

Analgesic Comparison of PENG/LFCN to FICB for Total Hip Arthroplasty

NCT05477641

Analgesia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Dysplasia Femoroacetabular Impingement Acetabular Labrum Tear

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FI Block

Fascia iliaca block consisting of up to 60 mL of 0.35% ropivicaine at a dose of 3 mg/kg (with adjuvants of 100 mcg clonidine \[per 60 mL\] and epinephrine 1:400,000)

Group Type EXPERIMENTAL

ropivicaine

Intervention Type DRUG

clonidine

Intervention Type DRUG

Epinephrine

Intervention Type DRUG

Local Injection

Local anesthetic in the hip joint consisting of 30cc of 0.5% Noropin

Group Type ACTIVE_COMPARATOR

Noropin

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ropivicaine

Intervention Type DRUG

clonidine

Intervention Type DRUG

Epinephrine

Intervention Type DRUG

Noropin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Scheduled for outpatient hip arthroscopy
* American Society of Anesthesiologists (ASA) 1-3

Exclusion Criteria

* Prior surgery on ipsilateral hip
* ASA 4-6
* Chronic narcotic usage over 6 months or more than the equivalent of 20mg of morphine per day
* Current or prior placement of a spinal cord stimulator or intrathecal pump for pain control purposes
* Allergy to amide local anesthetics
* Contraindication to regional anesthesia
* BMI \> 40
* Females who are pregnant or plan to get pregnant during the course of the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No